Coronavirus vaccine update: Covid drug, AstraZeneca vaccine current status



The total number of coronavirus cases across the world has now crossed the 7-million mark. A little more than five months have passed since the world first learnt of the deadly SARS-CoV-2 infection. Since then, researchers are scrambling to produce vaccine and also to repurpose existing treatments to help fight the uncontrollable virus. According to the World Health Organization (WHO), there are move than 115 teams speeding up efforts to produce a vaccine or an effective drug for Covid-19 treatment. Major pharmaceutical companies such as Gilead Sciences, AstraZeneca, Pfizer and Moderna are rushing to find a successful vaccine and some of them have succeeded in many ways.

Coronavirus treatment: Here are updates on coronavirus vaccine/drug development:
1. Coronavirus vaccine: AstraZeneca approaches Gilead over possible merger
AstraZeneca approached one of its US rivals, Gilead Sciences, last month over a potential merger, Bloomberg has reported.

A transatlantic tie-up would be the biggest healthcare merger yet, forging a company worth around 200 billion pounds, and bringing together firms leading the pharmaceutical industry’s efforts to develop a vaccine and treatments for Covid-19.


Comments

Popular posts from this blog

Before Bahubali 2, makers to release Bahubali 1 again

Samsung rolls out 'Made in India' privacy app for Galaxy A71, Galaxy A51

Truecaller version 12 with new features for Android users launched